11:06 AM EST, 01/08/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, declining 0.49% to 1,307.19 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies ( DBVT ) and Genfit ( GNFT ) , which rose 5.3% and 4.8% respectively. They were followed by pharmaceutical company Novo Nordisk ( NVO ) and biopharmaceutical company argenx (ARGX), which were up 2.2% and 1.9% respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis ( CLLS ) and semiconductor company Sequans Communications ( SQNS ) , which fell 7.9% and 5.2% respectively. They were followed by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company Grifols ( GRFS ) , which dropped 2.8% and 2.4% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Amarin ( AMRN ) and cruise line operator Carnival (CUK), which increased 2.7% and 0.6% respectively. They were followed by financial services company HSBC ( HSBC ) and mining company BHP Group ( BHP ) , which were up 0.5% and 0.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics ( ADAP ) and TC Biopharm ( TCBP ) , which shed 8.3% and 7.6% respectively. They were followed by biotech firm Trinity Biotech plc ( TRIB ) and biopharmaceutical company NuCana ( NCNA ) , which lost 6.8% and 5.7% respectively.